Brief: TriSalus Life Sciences Announces Commencement Of Exchange Offer, Consent Solicitation Relating To Series A Convertible Preferred Stock To Streamline Capital Structure
23/06/2025 22:37
June 23 (Reuters) - TriSalus Life Sciences Inc TLSI.O: TRISALUS LIFE SCIENCES ANNOUNCES COMMENCEMENT OF EXCHANGE OFFER AND CONSENT SOLICITATION RELATING TO SERIES A CONVERTIBLE PREFERRED STOCK TO STREAMLINE CAPITAL STRUCTURE Source text: ID:nBw2WqHSGa Further company coverage: TLSI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on TriSalus Life Sciences
See all newsTriSalus jumps after FDA clears liver treatment device
Brief: Trisalus Life Sciences Receives FDA Clearance For Trinav Advance
TriSalus Life Sciences Inc reports results for the quarter ended June 30 - Earnings Summary
TriSalus Life Sciences Q2 revenue beats estimates
TriSalus Life Sciences Inc expected to post a loss of 15 cents a share - Earnings Preview